The way healthcare technology assessments (HTAs) are conducted in Europe is changing. In less than a year, all new advanced therapeutic products and oncology drugs will be subject to a mandatory, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback